Results 91 to 100 of about 42,572 (273)
The aim of this study was to evaluate the quality of data in the Swedish Quality Register of Gynecologic Cancer (SQRGC on cervical cancer and vulvar cancer in terms of completeness, timeliness, comparability, and validity according to the International Agency for Research on Cancer methodology.
Maria Bjurberg+14 more
wiley +1 more source
Laparoscopic lateral suspension (LLS) with mesh provides effective apical and anterior vaginal support for pelvic organ prolapse, with anatomical success rates exceeding 90% and a low complication profile. This meta‐analysis reinforces LLS as a reliable surgical option, though longer follow‐up is needed to confirm its long‐term efficacy.
Qi Wang+3 more
wiley +1 more source
Vascular endothelial growth factor exression in uterine cervical cancer: correlation with clinicopathologic characteristics and survival [PDF]
Aim: This retrospective study was performed to determine the vascular endothelial growth factor (VEGF) expression in cervical cancer cells, and to examine its correlation with clinicopathologic characteristics and survival of patients.
Chekhun, V.F.+3 more
core
Recent studies have suggested the potential impact of high doses of chemotherapy on uterine volume, but this meta‐analysis did not find any significant decrease in uterine volume after chemotherapy. Abstract Introduction Uterine damage after pelvic radiotherapy or total‐body irradiation is well described, with decreased uterine volume and high ...
Eloïse Fraison+6 more
wiley +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen+3 more
wiley +1 more source
Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975 [PDF]
Background: To update the pattern of cancer mortality in Europe. Materials and methods: We analysed cancer mortality in 34 European countries during 2000-2004, with an overview of trends in 1975-2004 using data from the World Health Organization. Results:
Bertuccio, P.+6 more
core
This study analyzed 1356 cases using GenMineTOP, Japan's first dual DNA–RNA CGP test, and identified oncogenic alterations in 91.5% of cases. The RNA panel detected 105 fusion events, including 11 NTRK fusions. Furthermore, the analysis clarified the independent effects of genomic abnormalities and cancer type on RNA expression, providing valuable ...
Kousuke Watanabe+7 more
wiley +1 more source
Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC Expression
Partitioning Defective 6B (PARD6B), a polarity gene, functions as a scaffold node for the Par protein complex. In this study, we showed that highly expressed PARD6B could promote CRC growth by upregulating MYC expression while suppressing miR‐34c expression.
Kosuke Hirose+18 more
wiley +1 more source
Deep Phenotyping of Pathology‐Confirmed Benign Lesions in PTEN Hamartoma Tumor Syndrome Patients
Gastrointestinal, skin, thyroid, and vascular lesions are frequently present in PTEN Hamartoma Tumor Syndrome patients with little to no difference between sexes or by index status. Early‐onset lipomas (< 20 years) may be useful for early recognition of patients, and uterine polyps should be considered for inclusion as a PHTS‐related lesion.
Ane J. Schei‐Andersen+14 more
wiley +1 more source
THER: Integrative Web Tool for Tumour Hypoxia Exploration and Research
THER: Integrative Web Tool for Tumor Hypoxia Exploration and Research.
Yasi Zhang+12 more
wiley +1 more source